Explore the vast range of titles available.

COVID-19 is a critical pandemic that has affected human communities worldwide, and there is an urgent need to develop effective drugs. Although there are a large number of candidate drug compounds that may be useful for treating COVID-19, the evaluation of these drugs is time-consuming and costly. Thus, screening to identify potentially effective drugs prior to experimental validation is necessary. In this study, we applied the recently proposed method tensor decomposition (TD)-based unsupervised feature extraction (FE) to gene expression profiles of multiple lung cancer cell lines infected with severe acute respiratory syndrome coronavirus 2. We identified drug candidate compounds that significantly altered the expression of the 163 genes selected by TD-based unsupervised FE. Numerous drugs were successfully screened, including many known antiviral drug compounds such as C646, chelerythrine chloride, canertinib, BX-795, sorafenib, sorafenib, QL-X-138, radicicol, A-443654, CGP-60474, alvocidib, mitoxantrone, QL-XII-47, geldanamycin, fluticasone, atorvastatin, quercetin, motexafin gadolinium, trovafloxacin, doxycycline, meloxicam, gentamicin, and dibromochloromethane. The screen also identified ivermectin, which was first identified as an anti-parasite drug and recently the drug was included in clinical trials for SARS-CoV-2. The drugs screened using our strategy may be effective candidates for treating patients with COVID-19.

Unconsciousness can be induced by sleep and general anaesthesia alike; however, the extent to which these states differ is not well understood. In this study, we aimed to determine the similarities and differences between the unconscious states caused by sleep and those caused by anaesthesia, as well as investigate gene expression profiles by applying tensor decomposition-based unsupervised feature extraction to the two gene expression profiles. One of the two expression profiles was obtained from mice treated with sevoflurane, a type of inhaled anaesthesia, whereas the other two expression profiles were obtained from sleeping and awake mice. We selected two sets of genes (507 and 1048 genes) that were distinctly expressed between sleep- or anaesthesia-induced unconsciousness and the awake state. Both sets of genes include various distinct genes which are common to the state of unconsciousness during sleep and anaesthesia. The former was enriched in GABAergic synapses and the first layer of the frontal cortex, whereas the latter was enriched in glutamatergic synapses and the sixth layer of the prefrontal cortex. Additionally, both sets of genes were enriched in the RHO GTPase pathway. Based on these results, we hypothesised that L1 GABAergic neurons in the frontal cortex and L6 glutamatergic neurons in the prefrontal cortex use RHO GTPase to differentiate between the states of unconsciousness induced by general anaesthesia and sleep.

The evaluation of drug-gene-disease interactions is key for the identification of drugs effective against disease. However, at present, drugs that are effective against genes that are critical for disease are difficult to identify. Following a disease-centric approach, there is a need to identify genes critical to disease function and find drugs that are effective against them. By contrast, following a drug-centric approach comprises identifying the genes targeted by drugs, and then the diseases in which the identified genes are critical. Both of these processes are complex. Using a gene-centric approach, whereby we identify genes that are effective against the disease and can be targeted by drugs, is much easier. However, how such sets of genes can be identified without specifying either the target diseases or drugs is not known. In this study, a novel artificial intelligence-based approach that employs unsupervised methods and identifies genes without specifying neither diseases nor drugs is presented. To evaluate its feasibility, we applied tensor decomposition (TD)-based unsupervised feature extraction (FE) to perform drug repositioning from protein-protein interactions (PPI) without any other information. Proteins selected by TD-based unsupervised FE include many genes related to cancers, as well as drugs that target the selected proteins. Thus, we were able to identify cancer drugs using only PPI. Because the selected proteins had more interactions, we replaced the selected proteins with hub proteins and found that hub proteins themselves could be used for drug repositioning. In contrast to hub proteins, which can only identify cancer drugs, TD-based unsupervised FE enables the identification of drugs for other diseases. In addition, TD-based unsupervised FE can be used to identify drugs that are effective in in vivo experiments, which is difficult when hub proteins are used. In conclusion, TD-based unsupervised FE is a useful tool for drug repositioning using only PPI without other information.

The early and highly accurate prediction of COVID-19 based on medical images can speed up the diagnostic process and thereby mitigate disease spread; therefore, developing AI-based models is an inevitable endeavor. The presented work, to our knowledge, is the first to expand the model space and identify a better performing model among 10,000 constructed deep transfer learning (DTL) models as follows. First, we downloaded and processed 4481 CT and X-ray images pertaining to COVID-19 and non-COVID-19 patients, obtained from the Kaggle repository. Second, we provide processed images as inputs to four pre-trained deep learning models (ConvNeXt, EfficientNetV2, DenseNet121, and ResNet34) on more than a million images from the ImageNet database, in which we froze the convolutional and pooling layers pertaining to the feature extraction part while unfreezing and training the densely connected classifier with the Adam optimizer. Third, we generate and take a majority vote of two, three, and four combinations from the four DTL models, resulting in DTL models. Then, we combine the 11 DTL models, followed by consecutively generating and taking the majority vote of DTL models. Finally, we select DTL models from Experimental results from the whole datasets using five-fold cross-validation demonstrate that the best generated DTL model, named HC, achieving the best AUC of 0.909 when applied to the CT dataset, while ConvNeXt yielded a higher marginal AUC of 0.933 compared to 0.93 for HX when considering the X-ray dataset. These promising results set the foundation for promoting the large generation of models (LGM) in AI.

Background Although in silico drug discovery is necessary for drug development, two major strategies, a structure-based and ligand-based approach, have not been completely successful. Currently, the third approach, inference of drug candidates from gene expression profiles obtained from the cells treated with the compounds under study requires the use of a training dataset. Here, the purpose was to develop a new approach that does not require any pre-existing knowledge about the drug–protein interactions, but these interactions can be inferred by means of an integrated approach using gene expression profiles obtained from the cells treated with the analysed compounds and the existing data describing gene–gene interactions. Results In the present study, using tensor decomposition-based unsupervised feature extraction, which represents an extension of the recently proposed principal-component analysis-based feature extraction, gene sets and compounds with a significant dose-dependent activity were screened without any training datasets. Next, after these results were combined with the data showing perturbations in single-gene expression profiles, genes targeted by the analysed compounds were inferred. The set of target genes thus identified was shown to significantly overlap with known target genes of the compounds under study. Conclusions The method is specifically designed for large-scale datasets (including hundreds of treatments with compounds), not for conventional small-scale datasets. The obtained results indicate that two compounds that have not been extensively studied, WZ-3105 and CGP-60474, represent promising drug candidates targeting multiple cancers, including melanoma, adenocarcinoma, liver carcinoma, and breast, colon, and prostate cancers, which were analysed in this in silico study.

Identifying drug target genes in gene expression profiles is not straightforward. Because a drug targets proteins and not mRNAs, the mRNA expression of drug target genes is not always altered. In addition, the interaction between a drug and protein can be context dependent; this means that simple drug incubation experiments on cell lines do not always reflect the real situation during active disease. In this paper, I applied tensor-decomposition-based unsupervised feature extraction to the integrated analysis using a mathematical product of gene expression in various diseases and gene expression in the DrugMatrix dataset, where comprehensive data on gene expression during various drug treatments of rats are reported. I found that this strategy, in a fully unsupervised manner, enables researchers to identify a combined set of genes and compounds that significantly overlap with gene and drug interactions identified in the past. As an example illustrating the usefulness of this strategy in drug discovery experiments, I considered cirrhosis, for which no effective drugs have ever been proposed. The present strategy identified two promising therapeutic-target genes, CYPOR and HNFA4; for their protein products, bezafibrate was identified as a promising candidate drug, supported by in silico docking analysis.

Identifying the optimal bin sizes (or resolutions) for the integration of multiple Hi-C datasets is a challenge due to the fact that bin sizes must be common over multiple datasets. By contrast, the dependence of quality upon bin sizes can vary from dataset to dataset. Moreover, common structures should not be sought in bin sizes smaller than the optimal bin sizes, below which common structure cannot be the primary structure any more even after increasing the number of mapped short reads per bin. In this case, there are no common structures at finer resolutions, suggesting that individual Hi-C datasets may have to be analyzed separately in the bin sizes smaller than the optimal one. Thus, quality assessments of individual datasets have a limited ability to determine the best bin size for all datasets. In this study, we propose a novel application of tensor decomposition (TD) based unsupervised feature extraction (FE) to choose the optimal bin sizes for the integration of multiple Hi-C datasets. TD-based unsupervised FE exhibit phase transition-like phenomena through which the smallest possible bin size (or the highest resolution) can be automatically estimated empirically, without the need to manually set a threshold value for the integration of multiple Hi-C datasets, retrieved from GEO with GEO ID, GSE260760 and GSE255264. To our knowledge, ours is the first one that can optimize bin sizes over multiple Hi-C profiles without any tunable parameters.

Background Even though coexistence of multiple phenotypes sharing the same genomic background is interesting, it remains incompletely understood. Epigenomic profiles may represent key factors, with unknown contributions to the development of multiple phenotypes, and social-insect castes are a good model for elucidation of the underlying mechanisms. Nonetheless, previous studies have failed to identify genes associated with aberrant gene expression and methylation profiles because of the lack of suitable methodology that can address this problem properly. Methods A recently proposed principal component analysis (PCA)-based and tensor decomposition (TD)-based unsupervised feature extraction (FE) can solve this problem because these two approaches can deal with gene expression and methylation profiles even when a small number of samples is available. Results PCA-based and TD-based unsupervised FE methods were applied to the analysis of gene expression and methylation profiles in the brains of two social insects, Polistes canadensis and Dinoponera quadriceps . Genes associated with differential expression and methylation between castes were identified, and analysis of enrichment of Gene Ontology terms confirmed reliability of the obtained sets of genes from the biological standpoint. Conclusions Biologically relevant genes, shown to be associated with significant differential gene expression and methylation between castes, were identified here for the first time. The identification of these genes may help understand the mechanisms underlying epigenetic control of development of multiple phenotypes under the same genomic conditions.

Coronavirus disease 2019 (COVID-19) is raging worldwide. This potentially fatal infectious disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the complete mechanism of COVID-19 is not well understood. Therefore, we analyzed gene expression profiles of COVID-19 patients to identify disease-related genes through an innovative machine learning method that enables a data-driven strategy for gene selection from a data set with a small number of samples and many candidates. Principal-component-analysis-based unsupervised feature extraction (PCAUFE) was applied to the RNA expression profiles of 16 COVID-19 patients and 18 healthy control subjects. The results identified 123 genes as critical for COVID-19 progression from 60,683 candidate probes, including immune-related genes. The 123 genes were enriched in binding sites for transcription factors NFKB1 and RELA, which are involved in various biological phenomena such as immune response and cell survival: the primary mediator of canonical nuclear factor-kappa B (NF- κ B) activity is the heterodimer RelA-p50. The genes were also enriched in histone modification H3K36me3, and they largely overlapped the target genes of NFKB1 and RELA. We found that the overlapping genes were downregulated in COVID-19 patients. These results suggest that canonical NF- κ B activity was suppressed by H3K36me3 in COVID-19 patient blood.

In the current era of big data, the amount of data available is continuously increasing. Both the number and types of samples, or features, are on the rise. The mixing of distinct features often makes interpretation more difficult. However, separate analysis of individual types requires subsequent integration. A tensor is a useful framework to deal with distinct types of features in an integrated manner without mixing them. On the other hand, tensor data is not easy to obtain since it requires the measurements of huge numbers of combinations of distinct features; if there are m kinds of features, each of which has N dimensions, the number of measurements needed are as many as Nm, which is often too large to measure. In this paper, I propose a new method where a tensor is generated from individual features without combinatorial measurements, and the generated tensor was decomposed back to matrices, by which unsupervised feature extraction was performed. In order to demonstrate the usefulness of the proposed strategy, it was applied to synthetic data, as well as three omics datasets. It outperformed other matrix-based methodologies.